Chenevix-Trench G - Search Results

1

Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication.

Boonchai W, Green A, Ng J, Dicker A, Chenevix-Trench G. Boonchai W, et al. J Am Acad Dermatol. 2000 Oct;43(4):664-9. doi: 10.1067/mjd.2000.107939. J Am Acad Dermatol. 2000. PMID: 11004623

2

Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci.

Chenevix-Trench G, Jones K, Green AC, Duffy DL, Martin NG. Chenevix-Trench G, et al. Am J Hum Genet. 1992 Dec;51(6):1377-85. Am J Hum Genet. 1992. PMID: 1361101 Free PMC article.

3

Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate.

Chenevix-Trench G, Jones K, Green A, Martin N. Chenevix-Trench G, et al. Am J Hum Genet. 1991 May;48(5):1012-3. Am J Hum Genet. 1991. PMID: 1673285 Free PMC article. No abstract available.

4

Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma.

Shanley SM, Chenevix-Trench G, Palmer J, Hayward N. Shanley SM, et al. Carcinogenesis. 1995 Aug;16(8):2003-4. doi: 10.1093/carcin/16.8.2003. Carcinogenesis. 1995. PMID: 7634433

5

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.

Webb PM, Green A, Cummings MC, Purdie DM, Walsh MD, Chenevix-Trench G. Webb PM, et al. J Natl Cancer Inst. 1998 Nov 18;90(22):1729-34. doi: 10.1093/jnci/90.22.1729. J Natl Cancer Inst. 1998. PMID: 9827528

6

Expression of p53 in arsenic-related and sporadic basal cell carcinoma.

Boonchai W, Walsh M, Cummings M, Chenevix-Trench G. Boonchai W, et al. Arch Dermatol. 2000 Feb;136(2):195-8. doi: 10.1001/archderm.136.2.195. Arch Dermatol. 2000. PMID: 10677095

7

The spectrum of patched mutations in a collection of Australian basal cell carcinomas.

Evans T, Boonchai W, Shanley S, Smyth I, Gillies S, Georgas K, Wainwright B, Chenevix-Trench G, Wicking C. Evans T, et al. Hum Mutat. 2000;16(1):43-8. doi: 10.1002/1098-1004(200007)16:1<43::AID-HUMU8>3.0.CO;2-7. Hum Mutat. 2000. PMID: 10874304

8

Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma.

Boonchai W, Walsh M, Cummings M, Chenevix-Trench G. Boonchai W, et al. Arch Dermatol. 2000 Jul;136(7):937-8. doi: 10.1001/archderm.136.7.937. Arch Dermatol. 2000. PMID: 10891006 No abstract available.

9

Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype.

Spurdle AB, Webb PM, Purdie DM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Carcinogenesis. 2001 Jan;22(1):67-72. doi: 10.1093/carcin/22.1.67. Carcinogenesis. 2001. PMID: 11159743

10

The microsomal epoxide hydrolase Tyr113His polymorphism: association with risk of ovarian cancer.

Spurdle AB, Purdie DM, Webb PM, Chen X, Green A, Chenevix-Trench G. Spurdle AB, et al. Mol Carcinog. 2001 Jan;30(1):71-8. doi: 10.1002/1098-2744(200101)30:1<71::aid-mc1015>3.0.co;2-9. Mol Carcinog. 2001. PMID: 11255266

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

583 results

Search Page

Filters